Clinical trial
Acute Metabolic Effects of LAF 237 in Type 2 Diabetics
NCT00230464 · The University of Texas Health Science Center at San Antonio, Other · Completed
Key facts
| NCT number | NCT00230464 |
|---|---|
| Title | Acute Metabolic Effects of LAF 237 in Type 2 Diabetics |
| Official title | A Double-Blind, Placebo-Controlled, Randomized, Crossover Study to Explore the Acute Effects of LAF 237 on the Rate of Appearance and Disappearance of Glucose During the Overnight Post-Absorptive Period in Type 2 Diabetics |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | LAF 237 |
| Enrollment | 16 |
| Start date | Nov 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Sep 30, 2005 |
| Last update posted | Jan 4, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: